Effects of mixed carotenoids on adipokines and abdominal adiposity in children: A pilot study

Journal of Clinical Endocrinology and Metabolism

Volumn 102, Issue 6, 2017, Pages 1983-1990

  Canas, J Atilio ^a   Lochrie, Amanda ^b   McGowan, Amy Galena ^b   Hossain, Jobayer ^c   Schettino, Christopher ^a   Balagopal, P Babu ^a  

^a NEMOURS CHILDREN S CLINIC   (United States)

^b WOLFSON CHILDREN S HOSPITAL   (United States)

^c NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ALPHA CAROTENE; ASTAXANTHIN; BETA CAROTENE; CAROTENOID; GAMMA TOCOPHEROL; LYCOPENE; XANTHOPHYLL; ZEAXANTHIN; ADIPONECTIN; ADIPOQ PROTEIN, HUMAN; ALPHA-CAROTENE;

ABDOMINAL OBESITY; AGE DISTRIBUTION; ARTICLE; BODY MASS; CELL METABOLISM; CHILD; CHILDHOOD OBESITY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; INTENTION TO TREAT ANALYSIS; INTERVENTION STUDY; INTRAPERITONEAL FAT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SUBCUTANEOUS FAT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; WAIST TO HEIGHT RATIO; ABDOMINAL FAT; DIAGNOSTIC IMAGING; IMMUNOLOGY; INTRAABDOMINAL FAT; OBESITY, ABDOMINAL; PEDIATRIC OBESITY;

ABDOMINAL FAT; ADIPOKINES; ADIPONECTIN; BETA CAROTENE; CAROTENOIDS; CHILD; DOUBLE-BLIND METHOD; FEMALE; GAMMA-TOCOPHEROL; HUMANS; INTRA-ABDOMINAL FAT; LUTEIN; MAGNETIC RESONANCE IMAGING; MALE; OBESITY, ABDOMINAL; PEDIATRIC OBESITY; PILOT PROJECTS; SUBCUTANEOUS FAT; WAIST-HEIGHT RATIO; XANTHOPHYLLS; ZEAXANTHINS;

EID: 85020410282     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2017-00185     Document Type: Article

References (40)

1. Li C, Ford ES, Mokdad AH, Cook S. Recent trends in waist circumference and waist-height ratio among US children and adolescents. Pediatrics. 2006;118(5):e1390-e1398.
2. Garnett SP, Baur LA, Cowell CT. The prevalence of increased central adiposity in Australian school children 1985 to 2007. Obes Rev. 2011;12(11):887-896.
3. Beydoun MA, Shroff MR, Chen X, Beydoun HA, Wang Y, Zonderman AB. Serum antioxidant status is associated with metabolic syndrome among U. S. adults in recent national surveys. J Nutr. 2011;141(5):903-913.
4. Beydoun MA, Canas JA, Beydoun HA, Chen X, Shroff MR, Zonderman AB. Serum antioxidant concentrations and metabolic syndrome are associated among U. S. adolescents in recent national surveys. J Nutr. 2012;142(9):1693-1704.
5. Rao AV, Rao LG. Carotenoids and human health. Pharmacol Res 2007;55:207-216.
6. Bonet ML, Canas JA, Ribot J, Palou A. Carotenoids and their conversion products in the control of adipocyte function, adiposity and obesity. Arch Biochem Biophys. 2015;572:112-125.
7. Canas JA, Damaso L, Altomare A, Killen K, Hossain J, Balagopal PB. Insulin resistance and adiposity in relation to serum betacarotene levels. J Pediatr. 2012;161:58-64 e52.
8. Canas JA, Damaso L, Hossain J, Balagopal PB. Fatty acid binding proteins 4 and 5 in overweight prepubertal boys: effect of nutritional counselling and supplementation with an encapsulated fruit and vegetable juice concentrate. J Nutr Sci. 2015;4:e39.
9. Parker RS. Carotenoid and tocopherol composition of human adipose tissue. Am J Clin Nutr. 1988;47(1):33-36.
10. Palczewski G, Amengual J, Hoppel CL, von Lintig J. Evidence for compartmentalization of mammalian carotenoid metabolism. FASEB J. 2014;28(10):4457-4469.
11. Chung H-Y, Ferreira ALA, Epstein S, Paiva SA, Castaneda-Sceppa C, Johnson EJ. Site-specific concentrations of carotenoids in adipose tissue: relations with dietary and serum carotenoid concentrations in healthy adults. Am J Clin Nutr. 2009;90(3):533-539.
12. El-Sohemy A, Baylin A, Kabagambe E, Ascherio A, Spiegelman D, Campos H. Individual carotenoid concentrations in adipose tissue and plasma as biomarkers of dietary intake. Am J Clin Nutr. 2002; 76(1):172-179.
13. Bonet ML, Ribot J, Felipe F, Palou A. Vitamin A and the regulation of fat reserves. Cell Mol Life Sci. 2003;60(7):1311-1321.
14. Amengual J, Gouranton E, van Helden YG, Hessel S, Ribot J, Kramer E, Kiec-Wilk B, Razny U, Lietz G, Wyss A, Dembinska-Kiec A, Palou A, Keijer J, Landrier JF, Bonet ML, von Lintig J. Betacarotene reduces body adiposity of mice via BCMO1. PLoS One. 2011;6(6):e20644.
15. Tanner JM. Growth and maturation during adolescence. Nutr Rev. 1981;39(2):43-55.
16. Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z,Wei R, Curtin LR, Roche AF, Johnson CL. 2000 CDC growth charts for the United States: methods and development. Vital Health Stat 11. 2002;(246):1-190.
17. Burgert TS, Taksali SE, Dziura J, Goodman TR, Yeckel CW, Papademetris X, Constable RT, Weiss R, Tamborlane WV, Savoye M, Seyal AA, Caprio S. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab. 2006; 91(11):4287-4294.
18. Ross R, Freeman J, Hudson R, Janssen I. Abdominal obesity, muscle composition, and insulin resistance in premenopausal women. J Clin Endocrinol Metab. 2002;87(11):5044-5051.
19. Pollock NK, Bundy V, Kanto W, Davis CL, Bernard PJ, Zhu H, Gutin B, Dong Y. Greater fructose consumption is associated with cardiometabolic risk markers and visceral adiposity in adolescents. J Nutr. 2012;142(2):251-257.
20. Plutzky J. The PPAR-RXR transcriptional complex in the vasculature: energy in the balance. Circ Res. 2011;108(8):1002-1016.
21. Tamori Y, Masugi J, Nishino N, Kasuga M. Role of peroxisome proliferator-activated receptor-gamma in maintenance of the characteristics of mature 3T3-L1 adipocytes. Diabetes. 2002;51(7): 2045-2055.
22. Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, Komeda K, Satoh S, Nakano R, Ishii C, Sugiyama T, Eto K, Tsubamoto Y, Okuno A, Murakami K, Sekihara H, Hasegawa G, Naito M, Toyoshima Y, Tanaka S, Shiota K, Kitamura T, Fujita T, Ezaki O, Aizawa S, Nagai R, Tobe K, Kimura S, Kadowaki T. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell. 1999;4(4):597-609.
23. Lobo GP, Amengual J, LiHNM,Golczak M, Bonet ML, Palczewski K, von Lintig J. b,b-carotene decreases peroxisome proliferator receptor g activity and reduces lipid storage capacity of adipocytes in a b,b-carotene oxygenase 1-dependent manner. J Biol Chem. 2010;285(36):27891-27899.
24. Kabat GC, Heo M, Ochs-Balcom HM, LeBoff MS, Mossavar-Rahmani Y, Adams-Campbell LL, Nassir R, Ard J, Zaslavsky O, Rohan TE. Longitudinal association of measures of adiposity with serum antioxidant concentrations in postmenopausal women. Eur J Clin Nutr. 2016;70(1):47-53.
25. Östh M, Öst A, Kjolhede P, Strålfors P. The concentration of b-carotene in human adipocytes, but not the whole-body adipocyte stores, is reduced in obesity. PLoS One. 2014;9(1):e85610.
26. Landrier JF, Kasiri E, Karkeni E, Mihaly J, Beke G, Weiss K, Lucas R, Aydemir G, Salles J, Walrand S, de Lera AR, Rühl R. Reduced adiponectin expression after high-fat diet is associated with selective up-regulation of ALDH1A1 and further retinoic acid receptor signaling in adipose tissue. FASEB J. 2017;31(1):203-211.
27. Turer AT, Scherer PE. Adiponectin: mechanistic insights and clinical implications. Diabetologia. 2012;55(9):2319-2326.
28. Winer JC, Zern TL, Taksali SE, Dziura J, Cali AM, Wollschlager M, Seyal AA, Weiss R, Burgert TS, Caprio S. Adiponectin in childhood and adolescent obesity and its association with inflammatory markers and components of the metabolic syndrome. J Clin Endocrinol Metab. 2006;91(11):4415-4423.
29. Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, Imai Y, Nagai R, Kadowaki T. Measurement of the highmolecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care. 2006;29(6):1357-1362.
30. Liu Y, Chen H, Mu D, Fan J, Song J, Zhong Y, Li D, Xia M. Circulating retinoic acid levels and the development of metabolic syndrome. J Clin Endocrinol Metab. 2016;101(4):1686-1692.
31. Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, Schulthess T, Engel J, Brownlee M, Scherer PE. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J Biol Chem. 2003;278(11): 9073-9085.
32. Lara-Castro C, Luo N, Wallace P, Klein RL, Garvey WT. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes. 2006;55(1):249-259.
33. Suzuki K, Inoue T, Hashimoto S, Ochiai J, Kusuhara Y, Ito Y, Hamajima N. Association of serum carotenoids with high molecular weight adiponectin and inflammation markers among Japanese subjects. Clin Chim Acta. 2010;411(17-18):1330-1334.
34. Kameji H, Mochizuki K, Miyoshi N, Goda T. b-Carotene accumulation in 3T3-L1 adipocytes inhibits the elevation of reactive oxygen species and the suppression of genes related to insulin sensitivity induced by tumor necrosis factor-a. Nutrition. 2010; 26(11-12):1151-1156.
35. Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA, Sinha M, Olefsky JM. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes. 2002;51(10):2968-2974.
36. Balagopal P, George D, Yarandi H, Funanage V, Bayne E. Reversal of obesity-related hypoadiponectinemia by lifestyle intervention: a controlled, randomized study in obese adolescents. J Clin Endocrinol Metab. 2005;90(11):6192-6197.
37. RühlR, Landrier JF. Dietary regulation of adiponectin by direct and indirect lipid activators of nuclear hormone receptors. Mol Nutr Food Res. 2016;60(1):175-184.
38. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, Giugliano D. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA. 2003;289(14):1799-1804.
39. Ben Amara N, Tourniaire F, Maraninchi M, Attia N, Amiot-Carlin MJ,RaccahD, Vaĺero R, Landrier JF, Darmon P. Independent positive association of plasma b-carotene concentrations with adiponectin among non-diabetic obese subjects. Eur J Nutr. 2015;54(3):447-454.
40. Yoshida H, Yanai H, Ito K, Tomono Y, Koikeda T, Tsukahara H, Tada N. Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia. Atherosclerosis. 2010;209(2):520-523.